DK1308159T3 - Farmaceutisk sammensætning indeholdende en syre-labil omeprazol og fremgangsmåde til fremstilling deraf - Google Patents
Farmaceutisk sammensætning indeholdende en syre-labil omeprazol og fremgangsmåde til fremstilling derafInfo
- Publication number
- DK1308159T3 DK1308159T3 DK03001111T DK03001111T DK1308159T3 DK 1308159 T3 DK1308159 T3 DK 1308159T3 DK 03001111 T DK03001111 T DK 03001111T DK 03001111 T DK03001111 T DK 03001111T DK 1308159 T3 DK1308159 T3 DK 1308159T3
- Authority
- DK
- Denmark
- Prior art keywords
- enteric coating
- layer
- acid
- image
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9511094 | 1995-09-21 | ||
FR9514492A FR2742050A1 (fr) | 1995-12-07 | 1995-12-07 | Nouvelle composition contenant un benzimidazole acido-labile et son procede de preparation |
FR9602265A FR2745181A1 (fr) | 1996-02-23 | 1996-02-23 | Nouvelle composition contenant un benzimidazole acido-labile et son procede de preparation |
FR9605082A FR2747573A1 (fr) | 1996-04-23 | 1996-04-23 | Nouvelle composition contenant un benzimidazole acido-labile et son procede de preparation |
EP96931211A EP0859612B1 (en) | 1995-09-21 | 1996-09-23 | Pharmaceutical composition containing an acid-labile omeprazole and process for its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1308159T3 true DK1308159T3 (da) | 2005-02-14 |
Family
ID=27446956
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03001111T DK1308159T3 (da) | 1995-09-21 | 1996-09-23 | Farmaceutisk sammensætning indeholdende en syre-labil omeprazol og fremgangsmåde til fremstilling deraf |
DK00127495T DK1092434T3 (da) | 1995-09-21 | 1996-09-23 | Hidtil ukendt sammensætning indeholdende lansoprazol og fremgangsmåde til fremstilling deraf |
DK96931210T DK0854718T3 (da) | 1995-09-21 | 1996-09-23 | Hidtil ukendt sammensætning indeholdende en syrelabil benzimidazol og fremgangsmåde til fremstilling deraf |
DK96931211T DK0859612T3 (da) | 1995-09-21 | 1996-09-23 | Farmaceutisk sammensætning indeholdende en syre-labil omeprazol og fremgangsmåde til fremstilling deraf |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00127495T DK1092434T3 (da) | 1995-09-21 | 1996-09-23 | Hidtil ukendt sammensætning indeholdende lansoprazol og fremgangsmåde til fremstilling deraf |
DK96931210T DK0854718T3 (da) | 1995-09-21 | 1996-09-23 | Hidtil ukendt sammensætning indeholdende en syrelabil benzimidazol og fremgangsmåde til fremstilling deraf |
DK96931211T DK0859612T3 (da) | 1995-09-21 | 1996-09-23 | Farmaceutisk sammensætning indeholdende en syre-labil omeprazol og fremgangsmåde til fremstilling deraf |
Country Status (19)
Country | Link |
---|---|
US (3) | US6207198B1 (da) |
EP (4) | EP1308159B1 (da) |
JP (2) | JP3463266B2 (da) |
KR (1) | KR100350138B1 (da) |
CN (1) | CN1093855C (da) |
AT (4) | ATE261303T1 (da) |
AU (2) | AU6998796A (da) |
CA (1) | CA2231223C (da) |
CZ (1) | CZ293595B6 (da) |
DE (4) | DE69631834T2 (da) |
DK (4) | DK1308159T3 (da) |
ES (4) | ES2218054T3 (da) |
HU (1) | HU227566B1 (da) |
NO (1) | NO320489B1 (da) |
NZ (1) | NZ318501A (da) |
PL (1) | PL186605B1 (da) |
PT (4) | PT859612E (da) |
SK (1) | SK284291B6 (da) |
WO (2) | WO1997012580A2 (da) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3542189B2 (ja) * | 1995-03-08 | 2004-07-14 | 株式会社ルネサステクノロジ | 半導体装置の製造方法及び半導体装置 |
FR2758459B1 (fr) * | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
GB9710800D0 (en) * | 1997-05-23 | 1997-07-23 | Cipla Limited | Pharmaceutical composition and method of preparing it |
SI9700186B (sl) | 1997-07-14 | 2006-10-31 | Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. | Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin |
FR2774288B1 (fr) * | 1998-01-30 | 2001-09-07 | Ethypharm Sa | Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques |
DK173431B1 (da) | 1998-03-20 | 2000-10-23 | Gea Farmaceutisk Fabrik As | Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs |
ZA9810765B (en) * | 1998-05-28 | 1999-08-06 | Ranbaxy Lab Ltd | Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole. |
CA2340054C (en) | 1998-08-12 | 2005-10-18 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles |
US6174902B1 (en) | 1999-04-28 | 2001-01-16 | Sepracor Inc. | R-rabeprazole compositions and methods |
FR2793688B1 (fr) | 1999-05-21 | 2003-06-13 | Ethypharm Lab Prod Ethiques | Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques |
IL130602A0 (en) | 1999-06-22 | 2000-06-01 | Dexcel Ltd | Stable benzimidazole formulation |
ES2168043B1 (es) * | 1999-09-13 | 2003-04-01 | Esteve Labor Dr | Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido. |
WO2001028559A1 (fr) * | 1999-10-20 | 2001-04-26 | Eisai Co., Ltd. | Procede de stabilisation de composes benzimidazoles |
US6761901B1 (en) | 2000-05-02 | 2004-07-13 | Enzrel Inc. | Liposome drug delivery |
AU2001296908A1 (en) * | 2000-09-29 | 2002-04-08 | Geneva Pharmaceuticals, Inc. | Proton pump inhibitor formulation |
ES2191521B1 (es) * | 2000-11-22 | 2005-02-16 | Laboratorios Belmac, S.A. | Nueva formulacion galenica del omeprazol en forma de comprimidos, procedimiento para su preparacion y aplicaciones en medicina humana y en veterinaria. |
WO2003000169A1 (en) * | 2001-06-20 | 2003-01-03 | Takeda Chemical Industries, Ltd. | Method of manufacturing tablet |
US20030091634A1 (en) * | 2001-09-14 | 2003-05-15 | Pawan Seth | Delayed release tablet of venlafaxin |
CN1592611A (zh) * | 2001-09-28 | 2005-03-09 | 麦克内尔-Ppc股份有限公司 | 改良释放的剂型 |
US20030118647A1 (en) * | 2001-12-04 | 2003-06-26 | Pawan Seth | Extended release tablet of metformin |
ES2198195B1 (es) * | 2001-12-18 | 2004-10-01 | Laboratorios Del Dr. Esteve, S.A. | Forma de dosificacion farmaceutica oral comprimida, con recubrimiento enterico, que contiene un compuesto de bencimidazol labil en medio acido. |
JP2005523249A (ja) | 2002-01-09 | 2005-08-04 | エンズレル インコーポレイテッド | 多環式芳香族抗酸化剤または抗炎症化合物のリポソーム薬物配達 |
CN100378259C (zh) * | 2002-03-11 | 2008-04-02 | 陶氏环球技术公司 | 可逆转的热定形弹性纤维、其制造方法以及其制成的产品 |
TWI294939B (en) * | 2002-03-11 | 2008-03-21 | Dow Global Technologies Inc | Stretch fabrics with improved chemical resistance and durability |
US20030228363A1 (en) * | 2002-06-07 | 2003-12-11 | Patel Mahendra R. | Stabilized pharmaceutical compositons containing benzimidazole compounds |
US20050191353A1 (en) * | 2002-08-16 | 2005-09-01 | Amit Krishna Antarkar | Process for manufacture of stable oral multiple unit pharmaceutical composition containing benzimidazoles |
MY148805A (en) * | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
US20040086567A1 (en) * | 2002-10-30 | 2004-05-06 | Pawan Seth | Bioequivalent composition of itraconazole and a hydrophilic polymer |
JP2006513239A (ja) * | 2002-12-23 | 2006-04-20 | セルテック アメリカズ, インコーポレイテッド | 酸不安定性薬剤含有組成物 |
WO2004066982A1 (en) * | 2003-01-31 | 2004-08-12 | Ranbaxy Laboratories Limited | Stable oral benzimidazole compositions and processes for their preparation |
US20040162320A1 (en) * | 2003-02-14 | 2004-08-19 | Pawan Seth | Solid composition containing nisoldipine a mixture of polyethylene oxides and an antioxidant |
ES2234393B2 (es) * | 2003-04-29 | 2006-09-01 | Laboratorios Belmac, S.A. | "formulaciones de pelets de compuestos bencimidazolicos antiulcerosos y labiles al acido". |
US20050147663A1 (en) * | 2003-07-17 | 2005-07-07 | Mohan Mailatur S. | Method of treatment for improved bioavailability |
JP2007524646A (ja) * | 2003-07-17 | 2007-08-30 | ドクター レディズ ラボラトリーズ, インコーポレイテッド | 膨潤可能なコーティングを有する薬学的組成物 |
US20050013863A1 (en) | 2003-07-18 | 2005-01-20 | Depomed, Inc., A Corporation Of The State Of California | Dual drug dosage forms with improved separation of drugs |
US7390503B1 (en) | 2003-08-22 | 2008-06-24 | Barr Laboratories, Inc. | Ondansetron orally disintegrating tablets |
EP1660052A2 (en) * | 2003-09-03 | 2006-05-31 | Agi Therapeutics Limited | Proton pump inhibitor formulations, and methods of preparing and using such formulations |
TWI372066B (en) * | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
WO2005032554A1 (en) * | 2003-10-03 | 2005-04-14 | Astron Research Pvt. Ltd | A novel transmucosal delivery system |
US20050181052A1 (en) * | 2004-02-17 | 2005-08-18 | Patel Satishkumar A. | Lansoprazole microtablets |
US20050226923A1 (en) * | 2004-04-07 | 2005-10-13 | Gassert Chad M | Venlafaxine compositions in the form of microtablets |
CA2469427A1 (en) * | 2004-06-01 | 2005-12-01 | Pharmascience Inc. | Dry mixed dosage form containing benzimidazole derivatives |
US20050281876A1 (en) | 2004-06-18 | 2005-12-22 | Shun-Por Li | Solid dosage form for acid-labile active ingredient |
US20060024362A1 (en) * | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
TW200626185A (en) * | 2004-12-17 | 2006-08-01 | Bpsi Holdings Inc | Enteric film coating composition containing entericpolymer micronized with detackifier |
RU2007123436A (ru) * | 2004-12-20 | 2009-01-27 | Др. Редди` Лабораторис Лтд. (IN) | Фармацевтическая композиция, содержащая аморфные соединения бензимидазола, и способ ее приготовления |
EP1830823A2 (en) | 2004-12-23 | 2007-09-12 | Ranbaxy Laboratories Limited | Stable oral benzimidazole compositions and process of preparation thereof |
WO2006085335A2 (en) * | 2005-01-03 | 2006-08-17 | Lupin Limited | Pharmaceutical composition of acid labile substances |
EP1845982A2 (en) * | 2005-02-02 | 2007-10-24 | Ranbaxy Laboratories Limited | Stable oral benzimidazole compositions prepared by non-aqueous layering process |
CN100393304C (zh) * | 2005-02-28 | 2008-06-11 | 上海艾力斯医药科技有限公司 | 一种包含酸不稳定药物的微细颗粒及其制剂 |
US8673352B2 (en) | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
US20070009591A1 (en) * | 2005-07-07 | 2007-01-11 | Trivedi Jay S | ACE inhibitor formulation |
ES2278511B1 (es) * | 2005-07-28 | 2008-06-16 | Laboratorios Almirall S.A. | Comprimidos con perfil de disolucion mejorado. |
CA2633825A1 (en) * | 2005-12-20 | 2007-07-05 | Teva Pharmaceutical Industries Ltd. | Lansoprazole orally disintegrating tablets |
US20070141151A1 (en) * | 2005-12-20 | 2007-06-21 | Silver David I | Lansoprazole orally disintegrating tablets |
EP1813275A1 (en) * | 2005-12-20 | 2007-08-01 | Teva Pharmaceutical Industries Ltd | Lansoprazole orally disintegrating tablets |
US7579476B2 (en) * | 2006-02-24 | 2009-08-25 | Praktikatalyst Pharma, Llc | Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals |
RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
EP2026768B1 (en) * | 2006-06-01 | 2018-02-28 | Dexcel Pharma Technologies Ltd. | Multiple unit pharmaceutical formulation |
US8911787B2 (en) | 2008-02-26 | 2014-12-16 | Ranbaxy Laboratories Limited | Stable oral benzimidazole compositions and process of preparation thereof |
EP2535045A1 (en) * | 2011-06-15 | 2012-12-19 | Laboratorios Del. Dr. Esteve, S.A. | Pharmaceutical composition of lansoprazole |
CN102846571A (zh) * | 2012-09-29 | 2013-01-02 | 南京正科制药有限公司 | 一种埃索美拉唑镁微型片剂 |
CN103127026B (zh) * | 2013-02-05 | 2017-02-15 | 悦康药业集团有限公司 | 一种奥美拉唑肠溶胶囊及其制备方法 |
EP3288556A4 (en) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
US10736855B2 (en) | 2016-02-25 | 2020-08-11 | Dexcel Pharma Technologies Ltd. | Compositions comprising proton pump inhibitors |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
CN113116894A (zh) * | 2019-12-30 | 2021-07-16 | 北京康辰药业股份有限公司 | 一种抗肿瘤药物组合物以及提高化合物的溶解度的方法 |
GB202116644D0 (en) | 2021-11-18 | 2022-01-05 | Innovate Pharmaceuticals Ltd | Liquid composition |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE416649B (sv) * | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
IN148930B (da) * | 1977-09-19 | 1981-07-25 | Hoffmann La Roche | |
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
FR2471186A1 (fr) * | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
CH644116A5 (de) * | 1980-08-21 | 1984-07-13 | Hoffmann La Roche | Imidazolderivate. |
US4472409A (en) * | 1981-11-05 | 1984-09-18 | Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung | 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects |
SE8300736D0 (sv) * | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
DE3415971A1 (de) * | 1983-05-03 | 1984-11-08 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Acylierte benzimidazole, verfahren zu ihrer herstellung, ihre anwendung und sie enthaltende arzneimittel |
IL71664A (en) * | 1983-05-03 | 1987-11-30 | Byk Gulden Lomberg Chem Fab | Fluoroalkoxy compounds,process for their preparation and pharmaceutical compositions containing the same |
IL71665A (en) * | 1983-05-03 | 1988-05-31 | Byk Gulden Lomberg Chem Fab | Fluoro-(2-pyridyl-methylthio)-dioxolo-(and dioxino-)benzimidazoles,processes for their preparation and pharmaceutical compositions containing the same |
GR81595B (da) * | 1983-06-18 | 1984-12-11 | Wyeth John & Brother Ltd | |
CA1259070A (en) * | 1983-07-01 | 1989-09-05 | Upjohn Company (The) | Substituted 2-¬monoannelated(3,4-,4,5-, and 5,6-)- pyridylalkylenesulfinyl|-benzimidazoles |
US4575554A (en) * | 1983-12-05 | 1986-03-11 | The Upjohn Company | Substituted 2-pyridylmethylthio- and sulfinyl-benzimidazoles as gastric antisecretory agents |
IE57646B1 (en) * | 1983-12-16 | 1993-02-10 | Wyeth John & Brother Ltd | Derivatives of imidazoquinolines and analogues thereof |
IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
SE8404065D0 (sv) * | 1984-08-10 | 1984-08-10 | Haessle Ab | Novel biologically active compounds |
JPS6150978A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
AU4640985A (en) * | 1984-08-31 | 1986-03-06 | Nippon Chemiphar Co. Ltd. | Benzimidazole derivatives |
US5250527A (en) * | 1985-10-24 | 1993-10-05 | Smithkline & French Laboratories Limited | Pyridyl containing benzimidazoles, compositions and use |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
GB2189699A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated acid-labile medicaments |
JPS6327424A (ja) * | 1986-07-17 | 1988-02-05 | Shionogi & Co Ltd | 徐放性製剤およびその製造法 |
US4828848A (en) * | 1987-01-29 | 1989-05-09 | Owades Joseph L | Method of making salt-free pickles |
GB8820353D0 (en) * | 1988-08-26 | 1988-09-28 | Staniforth J N | Controlled release tablet |
US5126145A (en) * | 1989-04-13 | 1992-06-30 | Upsher Smith Laboratories Inc | Controlled release tablet containing water soluble medicament |
US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
US5232706A (en) * | 1990-12-31 | 1993-08-03 | Esteve Quimica, S.A. | Oral pharmaceutical preparation containing omeprazol |
YU48263B (sh) * | 1991-06-17 | 1997-09-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh. | Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola |
ATE156707T1 (de) * | 1991-06-21 | 1997-08-15 | Ilsan Ilac Ve Hammaddeleri San | Neues galenisches verfahren für omeprazol enthaltende pellets |
US5178867A (en) * | 1991-08-19 | 1993-01-12 | Alza Corporation | Dosage form for delivering drug in short-time period |
TW224049B (da) * | 1991-12-31 | 1994-05-21 | Sunkyong Ind Ltd | |
US5167964A (en) * | 1992-02-14 | 1992-12-01 | Warner-Lambert Company | Semi-enteric drug delivery systems and methods for preparing same |
FR2692146B1 (fr) * | 1992-06-16 | 1995-06-02 | Ethypharm Sa | Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention. |
US5374730A (en) * | 1993-11-04 | 1994-12-20 | Torcan Chemical Ltd. | Preparation of omeprazole and lansoprazole |
PL180395B1 (pl) | 1994-07-08 | 2001-01-31 | Astra Ab | Doustna farmaceutyczna tabletkowana postac dawkowania oraz sposób wytwarzania doustnej farmaceutycznej tabletkowanej postaci dawkowania PL PL PL PL PL PL PL PL PL PL |
SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
ES2094694B1 (es) * | 1995-02-01 | 1997-12-16 | Esteve Quimica Sa | Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion. |
US5945124A (en) * | 1995-07-05 | 1999-08-31 | Byk Gulden Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
US5840332A (en) * | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
SE9704869D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulaton II |
-
1996
- 1996-09-23 AT AT96931210T patent/ATE261303T1/de active
- 1996-09-23 AU AU69987/96A patent/AU6998796A/en not_active Abandoned
- 1996-09-23 SK SK314-98A patent/SK284291B6/sk not_active IP Right Cessation
- 1996-09-23 DK DK03001111T patent/DK1308159T3/da active
- 1996-09-23 EP EP03001111A patent/EP1308159B1/en not_active Expired - Lifetime
- 1996-09-23 JP JP51410897A patent/JP3463266B2/ja not_active Expired - Fee Related
- 1996-09-23 JP JP51410797A patent/JP3198337B2/ja not_active Expired - Fee Related
- 1996-09-23 EP EP96931211A patent/EP0859612B1/en not_active Expired - Lifetime
- 1996-09-23 US US09/043,145 patent/US6207198B1/en not_active Expired - Lifetime
- 1996-09-23 ES ES00127495T patent/ES2218054T3/es not_active Expired - Lifetime
- 1996-09-23 ES ES96931210T patent/ES2220989T3/es not_active Expired - Lifetime
- 1996-09-23 KR KR10-1998-0701884A patent/KR100350138B1/ko not_active IP Right Cessation
- 1996-09-23 AT AT03001111T patent/ATE286394T1/de active
- 1996-09-23 CZ CZ1998879A patent/CZ293595B6/cs not_active IP Right Cessation
- 1996-09-23 DE DE69631834T patent/DE69631834T2/de not_active Expired - Lifetime
- 1996-09-23 AT AT00127495T patent/ATE262332T1/de active
- 1996-09-23 PL PL96325838A patent/PL186605B1/pl not_active IP Right Cessation
- 1996-09-23 CA CA002231223A patent/CA2231223C/en not_active Expired - Fee Related
- 1996-09-23 WO PCT/IB1996/001054 patent/WO1997012580A2/en active IP Right Grant
- 1996-09-23 DK DK00127495T patent/DK1092434T3/da active
- 1996-09-23 EP EP96931210A patent/EP0854718B1/en not_active Expired - Lifetime
- 1996-09-23 AT AT96931211T patent/ATE241357T1/de active
- 1996-09-23 ES ES96931211T patent/ES2201200T3/es not_active Expired - Lifetime
- 1996-09-23 PT PT96931211T patent/PT859612E/pt unknown
- 1996-09-23 ES ES03001111T patent/ES2236628T3/es not_active Expired - Lifetime
- 1996-09-23 PT PT03001111T patent/PT1308159E/pt unknown
- 1996-09-23 DE DE69634160T patent/DE69634160T2/de not_active Expired - Lifetime
- 1996-09-23 DK DK96931210T patent/DK0854718T3/da active
- 1996-09-23 EP EP00127495A patent/EP1092434B1/en not_active Expired - Lifetime
- 1996-09-23 DE DE69628444T patent/DE69628444T2/de not_active Expired - Lifetime
- 1996-09-23 WO PCT/IB1996/001055 patent/WO1997012581A2/en active IP Right Grant
- 1996-09-23 AU AU69988/96A patent/AU713242B2/en not_active Ceased
- 1996-09-23 CN CN96197132A patent/CN1093855C/zh not_active Expired - Fee Related
- 1996-09-23 PT PT96931210T patent/PT854718E/pt unknown
- 1996-09-23 PT PT00127495T patent/PT1092434E/pt unknown
- 1996-09-23 DE DE69631981T patent/DE69631981T2/de not_active Expired - Lifetime
- 1996-09-23 NZ NZ318501A patent/NZ318501A/xx not_active IP Right Cessation
- 1996-09-23 DK DK96931211T patent/DK0859612T3/da active
- 1996-09-23 US US09/043,663 patent/US6159499A/en not_active Expired - Lifetime
- 1996-09-23 HU HU9900467A patent/HU227566B1/hu not_active IP Right Cessation
-
1998
- 1998-03-20 NO NO19981284A patent/NO320489B1/no not_active IP Right Cessation
-
1999
- 1999-12-30 US US09/538,845 patent/US6248355B1/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1308159T3 (da) | Farmaceutisk sammensætning indeholdende en syre-labil omeprazol og fremgangsmåde til fremstilling deraf | |
EE04800B1 (et) | Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks | |
ATE244002T1 (de) | Pharmazeutische formulierung mit omeprazol | |
LV11982A (lv) | Pantoprazolu saturosa medikamenta perorali lietojamas formas | |
ATE414509T1 (de) | Aus vielen einzeleinheiten zusammengesetzte tablettierte dosisform | |
NO960067L (no) | Nytt farmasöytisk preparat | |
IE64850B1 (en) | Therapeutically active substituted benzimidazole and process for its preparation | |
TH19832EX (th) | สูตรผสมทางเภสัชกรรมชนิดใหม่ที่ประกอบรวมด้วยเกลือแมกนีเซียมของออเมพราโซลที่มีรูปแบบทางกายภาพชนิดใหม่และวิธีสำหรับการผลิตเกลือนี้ |